Given the roles of these genes in chromatin remodeling, their frequent mutation points to a broader vulnerability in the SWI/SNF complex in chordoma, which may present novel opportunities for targeting chromatin regulation pathways in future therapeutic strategies. This evidence concerns the gene SMARCA1 and chordoma.